INSM1 and neuroendocrine neoplasm: First, the lesion was initially diagnosed on EUS-FNA cytology as a well-differentiated neuroendocrine tumor (NET), illustrating a recognized diagnostic pitfall when SPNs show focal expression of neuroendocrine markers (e.g., synaptophysin, INSM1) and when material is limited.